PRESERFLO®MicroShunt使

Rei Sakata1,2,3, Makoto Aihara4,5, Shiroaki Shirato5

  • 1Department of Ophthalmology, Graduate of Medicine, Faculty of Medicine, The University of Tokyo, Tokyo, Japan. reisakata-tky@umin.ac.jp.

Scientific reports
|November 18, 2024
PubMed
概括

在PRESERFLO® MicroShunt (PMS) 手术后,在35%的患者中发生了眼睛中血或眼睛出血. 这种并发症是经常发生的,无论管子插入的确切位置如何,这表明患者存在显著的风险.